 |
|
rosiglitazone maleate
The maleate salt of rosiglitazone, an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Rosiglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Avandia | | | | Abbreviation: | | ROS | | | | Code name: | | BRL49653 | | | | Chemical structure name: | | (+/-)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, ( Z )-2-Butenedioate (1:1) | | |
| Previous: | romidepsin, romiplostim, Romozin, ropivacaine hydrochloride, roquinimex | | Next: | Roxanol, Roxicodone, Rozerem, RP-Mycin, Rubidomycin |
|
|
